Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impact of thrombophilic gene mutations on thrombosis risk in patients with gastrointestinal carcinoma.

Cancer - 15 Jun 2002

Pihusch Rudolf, Danzl Gudrun, Scholz Michael, Harich Detlev, Pihusch Markus, Lohse Peter, Hiller Erhard

Abstract excerpt

BACKGROUND: Patients with malignancies have an increased risk for thromboembolic events due to the release of tissue factor by the tumor, damage to the vessel wall, and immobilization. Moreover, tumors may improve their growth and metastatic spread by utilizing the coagulation system. To date, no information is available on the additional role of prothrombotic mutations in these patients. METHODS: The prevalence...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Factor V

Share to Gastrointestinal Neoplasms

Share to Neoplasm Metastasis

Share to Prothrombin

Share to Thromboembolism

Source

Identifiers

PMID: 12115343
DOI: 10.1002/cncr.10590

Genes

MTHFR

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impact of thrombophilic gene mutations on thrombosis risk in patients with gastrointestinal carcinoma.PMID 12115343Read ↗

Do thrombophilic gene mutations have a role on thromboembolic events in cancer patients?Semantic proximity Read ↗

Prevalence of Factor V 1691 G-A (Leiden) and prothrombin G20210A polymorphisms and the risk of venous thrombosis among cancer patients.Semantic proximity Read ↗

Malignancies, prothrombotic mutations, and the risk of venous thrombosis.Semantic proximity Read ↗

Factor V Leiden, prothrombin 20210A and the risk of venous thrombosis among cancer patients.Semantic proximity Read ↗

Prevalence of factor V Leiden, FII G20210A, FXIII Val34Leu and MTHFR C677T polymorphisms in cancer patients with and without venous thrombosis.Semantic proximity Read ↗

Thrombophilia and risk of venous thrombosis in patients with cancer.Semantic proximity Read ↗

Factor V Leiden mutation increases the risk for venous thromboembolism in cancer patients - results from the Vienna Cancer And Thrombosis Study (CATS).Semantic proximity Read ↗

Cancer genetic profile and risk of thrombosis.Semantic proximity Read ↗

No significant association between the promoter region polymorphisms of factor VII gene and risk of venous thrombosis in cancer patients.Semantic proximity Read ↗

The efficacy of tissue factor -603A/G and +5466A>G polimorphisms at the development of venous thromboembolism in cancer patients.Semantic proximity Read ↗

The factor V leiden mutation and the risk of venous thromboembolism in gynecologic oncology patients1.Semantic proximity Read ↗

Polymorphisms of the coagulation system and risk of cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.